Application
TWS119 has been used as glycogen synthase kinase-3β (GSK-3β) GSK3β inhibitor.
Biochem/physiol Actions
TWS119 favors the γδT cells survival and proliferation by activating the mammalian target of rapamycin (mTOR) pathway. It also promotes the expression of T-cell factor 1 (TCF1) and modulates cytokine production.
TWS119 is a potent Glycogen synthase kinase-3β (GSK-3β) inhibitor that can induce neurogenesis in embryonic stem cells (ESCs).
Packaging
5, 25 mg in glass bottle
This product has met the following criteria to qualify for the following awards: